Skip to content

What medical condition is treated by glycopyrronium?

4 min read

First approved by the FDA in 1961 for peptic ulcers, the uses for glycopyrronium have since expanded dramatically. Understanding what medical condition is treated by glycopyrronium is key, as its application depends heavily on the specific formulation—topical, inhaled, or oral.

Quick Summary

Glycopyrronium is a versatile anticholinergic medication with various formulations to treat specific conditions like chronic obstructive pulmonary disease (COPD), severe drooling, and excessive underarm sweating (hyperhidrosis).

Key Points

  • COPD Treatment: Glycopyrronium is used as a long-acting bronchodilator for the long-term maintenance of Chronic Obstructive Pulmonary Disease (COPD).

  • Excessive Sweating: The topical formulation of glycopyrronium, applied via medicated wipes, is prescribed for treating primary axillary hyperhidrosis.

  • Severe Drooling: An oral solution of glycopyrronium is used to reduce chronic, severe drooling (sialorrhea) in children with neurological conditions.

  • Surgical Adjunct: Intravenous glycopyrronium is administered during surgery to reduce secretions and prevent cardiac reflexes.

  • Mechanism of Action: As an anticholinergic, glycopyrronium works by blocking muscarinic receptors to inhibit secretions and relax smooth muscles.

  • Key Side Effects: Common side effects include dry mouth, constipation, and urinary retention.

  • Major Contraindications: Glycopyrronium is not suitable for patients with conditions like glaucoma, myasthenia gravis, or intestinal obstruction.

In This Article

Glycopyrronium, also known as glycopyrrolate, is an anticholinergic medication that works by blocking muscarinic receptors in the body, which helps to reduce the activity of certain glands and relax muscles. Its specific use depends on its formulation and administration route, allowing it to target a wide array of medical conditions effectively.

Glycopyrronium for chronic obstructive pulmonary disease (COPD)

In its inhaled form, glycopyrronium is a long-acting muscarinic antagonist (LAMA) used for the long-term maintenance treatment of COPD, a progressive lung disease that includes chronic bronchitis and emphysema.

How inhaled glycopyrronium works for COPD

By blocking muscarinic receptors in the airways, inhaled glycopyrronium helps relax the muscles around the lungs, which widens the airways and makes it easier to breathe. This effect is rapid and sustained, providing consistent relief from symptoms. For many patients, this leads to significant improvements in lung function, a reduction in the need for rescue medication, and better overall quality of life.

Key benefits of inhaled glycopyrronium for COPD include:

  • Improved forced expiratory volume in one second (FEV1)
  • Reduced risk and frequency of COPD exacerbations
  • Improved exercise tolerance and reduced breathlessness
  • Effective both as a monotherapy and in combination with other COPD medications

Treating excessive sweating (hyperhidrosis)

Topical glycopyrronium, delivered via medicated wipes, is FDA-approved for treating primary axillary hyperhidrosis, or excessive underarm sweating, in adults and children nine years and older.

How topical glycopyrronium works for hyperhidrosis

The topical formulation blocks the natural substance that activates sweat glands in the underarm area, effectively reducing sweat production. This offers a targeted solution for those who find over-the-counter antiperspirants ineffective. Users apply the medicated cloth once daily to clean, dry underarm skin.

Managing severe drooling (sialorrhea)

Oral glycopyrronium solution is prescribed to manage chronic, severe drooling in children and adolescents with neurological conditions, such as cerebral palsy.

How oral glycopyrronium works for drooling

As an anticholinergic, the oral solution decreases saliva production by blocking receptors in the salivary glands. Clinical trials have shown its effectiveness in significantly reducing drooling severity and improving quality of life for both the child and their caregivers. The dosage is carefully adjusted based on the child's weight and response to treatment.

Other therapeutic applications of glycopyrronium

Beyond these common uses, glycopyrronium has several other applications, particularly in a hospital setting and for specific gastrointestinal issues.

  • During anesthesia: Intravenous glycopyrronium is used to reduce salivary, tracheobronchial, and pharyngeal secretions before and during surgery. It also helps block cardiac reflexes during intubation and protects against the muscarinic effects of reversal agents like neostigmine.
  • Peptic ulcers: Glycopyrronium was historically used as an adjunctive therapy for peptic ulcers by reducing stomach acid production. While other treatments are now more common, this was one of its original applications.

Comparative overview of glycopyrronium applications

Medical Condition Formulation Mechanism of Action Common Side Effects
COPD Inhaled via DPI or nebulizer Relaxes airway muscles by blocking muscarinic receptors. Dry mouth, urinary tract infections, headache, back pain.
Hyperhidrosis Topical medicated wipes Blocks sweat gland activity in the underarm area. Dry mouth, local skin irritation, blurred vision.
Severe Drooling Oral solution Reduces saliva production by blocking muscarinic receptors in salivary glands. Constipation, dry mouth, blurred vision, urinary retention.
Anesthesia Support Intravenous (injection) Decreases secretions and blocks vagal reflexes during surgery. Tachycardia, dry mouth, blurred vision.

Side effects and considerations

As an anticholinergic medication, glycopyrronium can cause a range of side effects by blocking the action of acetylcholine. Common adverse effects include dry mouth, constipation, and urinary retention. For inhaled glycopyrronium, common side effects may include headaches and back or joint pain. Topical use can cause localized skin irritation and, in some cases, dry mouth.

Patients should also be aware of more serious concerns. Because glycopyrronium reduces the body's ability to sweat, it can increase the risk of heat stroke, especially during exercise or in hot weather. Blurred vision is also a potential side effect, and patients should not drive or operate heavy machinery until they know how the medication affects them.

Contraindications and warnings

Glycopyrronium is contraindicated in certain medical conditions that can be worsened by anticholinergic effects, including:

  • Glaucoma
  • Myasthenia gravis
  • Urinary obstruction or retention
  • Severe ulcerative colitis or toxic megacolon
  • Intestinal obstruction or paralytic ileus

It is vital to discuss your full medical history with a healthcare provider before starting glycopyrronium to ensure it is safe and appropriate for your condition. For more information, consult reliable medical resources such as MedlinePlus.

Conclusion

Glycopyrronium is a versatile anticholinergic medication with distinct applications depending on its formulation. As an inhaler, it significantly improves lung function for patients with COPD. In its topical form, it offers an effective treatment for excessive underarm sweating. Orally, it provides relief from severe drooling in children with neurological disorders. Despite its efficacy, it's essential to be aware of potential side effects and contraindications, and to use the medication strictly under a doctor's supervision due to its potent anticholinergic effects.

Frequently Asked Questions

As an inhaled long-acting muscarinic antagonist (LAMA), glycopyrronium treats COPD by relaxing the muscles around the airways. This widens the airways, making it easier for patients to breathe and reducing the risk of exacerbations.

Inhaled glycopyrronium is for respiratory conditions like COPD, relaxing the airways. Topical glycopyrronium is applied to the skin, typically the underarms, to block sweat gland activity and treat excessive sweating (hyperhidrosis).

Yes, glycopyrronium is used in children for specific conditions. For example, an oral solution is approved for managing severe drooling in children aged 3 to 16 with certain neurological disorders. Topical wipes for hyperhidrosis are approved for children aged 9 and older.

Common side effects include dry mouth, constipation, headache, and blurred vision. Topical use might cause local skin irritation, while oral or inhaled versions can lead to systemic anticholinergic effects.

No, glycopyrronium is typically contraindicated in patients with glaucoma, especially angle-closure glaucoma. Its anticholinergic properties can increase pressure in the eyes, which can be dangerous.

Topical glycopyrronium wipes are applied to clean, dry underarm skin, usually once daily. It's crucial to wash hands immediately after application to avoid blurred vision from accidental eye contact.

If you experience symptoms of overheating like hot, red skin, call a doctor immediately. Glycopyrronium reduces sweating, which can lead to heat prostration in high temperatures. Avoid strenuous exercise and hot environments while on this medication.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.